Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation
ConditionLiver Transplantation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse
About this trial
Liver transplantation carries a substantial risk of bleeding, making precise haemostasis control essential, although assessing coagulation remains challenging. Quantra, a bedside viscoelastic testing device using sonorheometric methods, offers an innovative approach to guiding haemostatic management during surgery. The study aims to determine whether a Quantra-guided transfusion can reduce transfusion and bleeding during liver transplantation when compared to a conventional transfusion approach.
Eligibility criteria
Qualifiers
Patients aged 18 years or older
Patient with ESLD undergoing liver transplantation
Individuals affiliated with or beneficiaries of a social security scheme
Free and informed written consent obtained in writing from the patient, or where applicable from the trusted person/family member/close relative
Disqualifiers
None
Trial design
Treatments tested in this trial
- Transfusion algorithm based on Quantra®
- Conventional transfusion algorithm
Treatment groups
56 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov